Medical Device News Magazine

RSIP Vision: An Innovative Set of AI Modules for Enhanced Medical Ultrasound Applications is Introduced

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

June 22, 2020

RSIP Vision has announced a new set of AI-based medical ultrasound modules.

RSIP Vision notes these advanced modules will serve as AI-based building blocks for a variety of applications, ranging from automated diagnosis, measurement, and volume estimation, to advanced procedure planning and in-op guided tracking.

When integrated into third-party ultrasound carts, PACS systems, and proprietary cloud platforms, these modules will enable a new set of innovative capabilities in a wide range of domains, such as urology, OBGYN, general imaging, cardiac procedures, and more.

These new building blocks will enable new applications, including:

Biopsy guidance – The modules allow for real-time, AI-guided needle biopsy procedures, while providing an improved understanding of the lesion or mass. They utilize automated tissue segmentation capabilities, clearly separate the abnormal tissue from the healthy one, and provide the surgeon with all the necessary data required to get to the desired area quickly and precisely.

Automated measurements and function evaluation in Cardiac Ultrasound – These AI modules perform fully automated segmentation of the heart chambers from different ultrasound views, which automates the most important measurements, such as Ejection Fraction, CO, EDA, and EDA. It also evaluates the performance of main heart functions, such as motion of the valves and walls, and detects and classifies abnormalities.

3D Reconstruction – In many cases, the sonographer will be able to demonstrate only a few slices of the organ at focus. The reconstruction function can build the complete organ from sparse information and help the interventional surgeon navigate accurately for biopsy or ablation procedures.

Patient Screening – Integrated into cloud-based settings, these AI capabilities can perform automated analysis of ongoing ultrasound studies, provide triage and second-opinion analysis, detect irregularities and potential errors, prioritize workflow, and boost population healthcare management capabilities.

“Ultrasound is extremely user-dependent and can be challenging to interpret. These innovative AI modules help medical teams make quick and accurate clinical decisions and lower the dependence on teams’ experience,” says Dr. Rabeeh Fares, Radiologist; Department of Diagnostic Radiology, Sourasky Medical Center, Tel Aviv, Israel.

The usage of ultrasound imaging plays a crucial role in the diagnosis and treatment of many pathologies. Its wide availability and relatively low cost, with no radiation considerations, makes it the preferred imaging modality across a number of clinical fields. It can immediately detect pathologies and injuries across the entire healthcare pathway and is useful in a variety of settings, from ER triage and intensive care units to point-of-care settings and outpatient clinics.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”